-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Htg Molecular Diagnostics, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2022.
- Htg Molecular Diagnostics, Inc Nonoperating Income (Expense) for the quarter ending March 31, 2023 was -$40K, a 83.6% increase year-over-year.
- Htg Molecular Diagnostics, Inc Nonoperating Income (Expense) for the twelve months ending March 31, 2023 was -$551K, a 176% decline year-over-year.
- Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2022 was -$754K, a 208% decline from 2021.
- Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2021 was $701K.
- Htg Molecular Diagnostics, Inc annual Nonoperating Income (Expense) for 2020 was -$1.27M, a 280% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)